QIAGEN EBITDA 2006-2021 | QGEN

QIAGEN annual and quarterly EBITDA history from 2006 to 2021. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • QIAGEN EBITDA for the quarter ending March 31, 2021 was $0.227B, a 81.11% increase year-over-year.
  • QIAGEN EBITDA for the twelve months ending March 31, 2021 was $0.736B, a 183.93% increase year-over-year.
  • QIAGEN 2020 annual EBITDA was $0.634B, a 157.54% increase from 2019.
  • QIAGEN 2019 annual EBITDA was $0.246B, a 51.61% decline from 2018.
  • QIAGEN 2018 annual EBITDA was $0.509B, a 28.87% increase from 2017.
QIAGEN Annual EBITDA
(Millions of US $)
2020 $634
2019 $246
2018 $509
2017 $395
2016 $332
2015 $391
2014 $378
2013 $263
2012 $368
2011 $267
2010 $331
2009 $301
2008 $251
2007 $195
2006 $149
2005 $98
QIAGEN Quarterly EBITDA
(Millions of US $)
2021-03-31 $227
2020-12-31 $224
2020-09-30 $107
2020-06-30 $178
2020-03-31 $126
2019-12-31 $143
2019-09-30 $-141
2019-06-30 $132
2019-03-31 $113
2018-12-31 $148
2018-09-30 $134
2018-06-30 $117
2018-03-31 $109
2017-12-31 $105
2017-09-30 $122
2017-06-30 $84
2017-03-31 $84
2016-12-31 $66
2016-09-30 $107
2016-06-30 $87
2016-03-31 $72
2015-12-31 $115
2015-09-30 $101
2015-06-30 $89
2015-03-31 $86
2014-12-31 $88
2014-09-30 $102
2014-06-30 $97
2014-03-31 $91
2013-12-31 $88
2013-09-30 $85
2013-06-30 $15
2013-03-31 $74
2012-12-31 $103
2012-09-30 $89
2012-06-30 $94
2012-03-31 $82
2011-12-31 $27
2011-09-30 $77
2011-06-30 $85
2011-03-31 $77
2010-12-31 $89
2010-09-30 $50
2010-06-30 $43
2010-03-31 $79
2009-12-31 $69
2009-09-30 $53
2009-06-30 $51
2009-03-31 $68
2008-12-31 $76
2008-09-30 $63
2008-06-30 $42
2008-03-31 $71
2007-12-31 $66
2007-09-30 $49
2007-06-30 $42
2007-03-31 $39
2006-12-31 $126
2006-09-30 $28
2006-06-30 $113
2006-03-31 $109
2005-12-31 $26
2005-09-30 $26
2005-06-30 $24
2005-03-31 $27
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $10.914B $1.870B
Qiagen NV produces biomedical and genetic products, products for separating and purifying nucleic acids for gene-based drug screening, nucleic acid-based clinical diagnostics, genetic vaccination and gene therapy.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $150.360B 10.42
Amgen (AMGN) United States $139.484B 15.05
CSL (CSLLY) Australia $104.441B 0.00
Moderna (MRNA) United States $87.874B 175.08
Gilead Sciences (GILD) United States $86.250B 9.18
Illumina (ILMN) United States $66.163B 95.40
Biogen (BIIB) United States $59.716B 13.67
BioNTech SE (BNTX) Germany $57.615B 41.78
Regeneron Pharmaceuticals (REGN) United States $55.994B 16.03
Vertex Pharmaceuticals (VRTX) United States $49.966B 20.58
Alexion Pharmaceuticals (ALXN) United States $40.148B 15.25
BeiGene (BGNE) Cayman Islands $31.850B 0.00
Genmab (GMAB) Denmark $28.702B 33.65
Seagen (SGEN) United States $28.416B 49.08
Genmab (GNMSF) Denmark $26.975B 6.20
Horizon Therapeutics Public (HZNP) Ireland $20.969B 26.81
Exact Sciences (EXAS) United States $20.910B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.827B 0.00
Alnylam Pharmaceuticals (ALNY) United States $19.397B 0.00
CureVac (CVAC) Germany $18.284B 0.00
Incyte (INCY) United States $18.161B 35.90
Bio-Techne Corp (TECH) United States $17.266B 90.79
Bio-Rad Laboratories (BIO.B) United States $17.251B 41.91
ARGENX SE-ADR (ARGX) Netherlands $16.144B 0.00
Zai Lab (ZLAB) China $16.099B 0.00
Novavax (NVAX) United States $15.536B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.998B 136.78
Guardant Health (GH) United States $12.230B 0.00
Repligen (RGEN) United States $10.515B 94.81
CRISPR Therapeutics AG (CRSP) Switzerland $9.623B 0.00
Denali Therapeutics (DNLI) United States $9.089B 326.09
Mirati Therapeutics (MRTX) United States $8.850B 0.00
Fate Therapeutics (FATE) United States $8.440B 0.00
Acceleron Pharma (XLRN) United States $8.100B 0.00
Exelixis (EXEL) United States $7.202B 114.90
AbCellera Biologics (ABCL) $7.017B 0.00
Ascendis Pharma (ASND) Denmark $7.011B 0.00
Ultragenyx Pharmaceutical (RARE) United States $6.864B 0.00
Sarepta Therapeutics (SRPT) United States $6.861B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $6.834B 0.00
Halozyme Therapeutics (HALO) United States $6.093B 33.43
Vir Biotechnology (VIR) United States $5.921B 0.00
Intellia Therapeutics (NTLA) United States $5.813B 0.00
Twist Bioscience (TWST) United States $5.605B 0.00
Beam Therapeutics (BEAM) United States $5.554B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $5.460B 19.78
Adaptive Biotechnologies (ADPT) United States $5.438B 0.00
Legend Biotech (LEGN) United States $5.307B 0.00
Reata Pharmaceuticals (RETA) United States $5.296B 0.00
I-Mab (IMAB) China $5.200B 0.00
Galapagos (GLPG) Belgium $5.198B 0.00
NeoGenomics (NEO) United States $5.083B 862.00
Blueprint Medicines (BPMC) United States $5.070B 15.44
Apellis Pharmaceuticals (APLS) United States $5.000B 0.00
ACADIA Pharmaceuticals (ACAD) United States $4.392B 0.00
Certara (CERT) United States $4.118B 0.00
SpringWorks Therapeutics (SWTX) United States $4.034B 0.00
Alkermes (ALKS) Ireland $4.016B 0.00
Arvinas (ARVN) United States $3.999B 0.00
Arena Pharmaceuticals (ARNA) United States $3.957B 0.00
Emergent Biosolutions (EBS) United States $3.403B 6.78
Intra-Cellular Therapies (ITCI) United States $3.385B 0.00
Berkeley Lights (BLI) United States $3.256B 0.00
Insmed (INSM) United States $3.111B 0.00
Dicerna Pharmaceuticals (DRNA) United States $2.873B 0.00
Amicus Therapeutics (FOLD) United States $2.826B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $2.815B 0.00
MorphoSys AG (MOR) Germany $2.694B 0.00
Vericel (VCEL) United States $2.669B 719.75
Sorrento Therapeutics (SRNE) United States $2.549B 0.00
Editas Medicine (EDIT) United States $2.538B 0.00
Global Blood Therapeutics (GBT) United States $2.531B 0.00
ALX Oncology Holdings (ALXO) United States $2.400B 0.00
Bluebird Bio (BLUE) United States $2.300B 0.00
Myriad Genetics (MYGN) United States $2.291B 0.00
Morphic Holding (MORF) United States $2.287B 0.00
Kymera Therapeutics (KYMR) United States $2.276B 0.00
Instil Bio (TIL) United States $2.189B 0.00
Heska (HSKA) United States $2.150B 937.36
Revance Therapeutics (RVNC) United States $2.146B 0.00
Bionano Genomics (BNGO) United States $2.114B 0.00
Myovant Sciences (MYOV) United Kingdom $2.067B 0.00
Ligand Pharmaceuticals (LGND) United States $2.059B 34.44
Deciphera Pharmaceuticals (DCPH) United States $2.053B 0.00
Seer (SEER) $2.033B 0.00
Prothena (PRTA) Ireland $1.992B 0.00
Atea Pharmaceuticals (AVIR) United States $1.966B 0.00
Amarin (AMRN) Ireland $1.954B 0.00
Inovio Pharmaceuticals (INO) United States $1.906B 0.00
Seres Therapeutics (MCRB) United States $1.883B 0.00
C4 Therapeutics (CCCC) United States $1.822B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.820B 0.00
Castle Biosciences (CSTL) United States $1.801B 0.00
Arcus Biosciences (RCUS) United States $1.767B 0.00
Genetron Holdings (GTH) China $1.759B 0.00
Zymeworks (ZYME) Canada $1.742B 0.00
Protagonist Therapeutics (PTGX) United States $1.742B 0.00
Sangamo Therapeutics (SGMO) United States $1.692B 0.00
PHARMA MAR SA (PHMMF) Spain $1.691B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.691B 0.00
BioAtla (BCAB) United States $1.675B 0.00
UniQure (QURE) Netherlands $1.659B 0.00
PureTech Health (PRTC) United States $1.651B 0.00
REGENXBIO (RGNX) United States $1.602B 0.00
Y-mAbs Therapeutics (YMAB) United States $1.581B 0.00
Alector (ALEC) United States $1.565B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.530B 0.00
Precigen (PGEN) United States $1.513B 0.00
Cytokinetics (CYTK) United States $1.509B 0.00
Codexis (CDXS) United States $1.415B 0.00
NGM Biopharmaceuticals (NGM) United States $1.409B 0.00
Avid Bioservices (CDMO) United States $1.406B 0.00
Zealand Pharma (ZEAL) Denmark $1.392B 0.00
Northwest Biotherapeutics (NWBO) United States $1.348B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.319B 0.00
Nurix Therapeutics (NRIX) United States $1.284B 0.00
Ocugen (OCGN) United States $1.257B 0.00
Shattuck Labs (STTK) United States $1.250B 0.00
KaloBios Pharmaceuticals (HGEN) United States $1.247B 0.00
Repare Therapeutics (RPTX) Canada $1.237B 0.00
MiMedx (MDXG) United States $1.235B 0.00
Celldex Therapeutics (CLDX) United States $1.230B 0.00
Keros Therapeutics (KROS) United States $1.193B 0.00
Pliant Therapeutics (PLRX) United States $1.185B 0.00
Zealand Pharma (ZLDPF) Denmark $1.167B 0.00
Agenus (AGEN) United States $1.152B 0.00
Mesoblast (MESO) Australia $1.107B 0.00
Coherus BioSciences (CHRS) United States $1.098B 0.00
Scholar Rock Holding (SRRK) United States $1.089B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.083B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.066B 33.65
Dynavax Technologies (DVAX) United States $1.052B 0.00
Mersana Therapeutics (MRSN) United States $1.036B 0.00
MannKind (MNKD) United States $1.009B 0.00
VBI Vaccines (VBIV) United States $1.002B 0.00
Avidity Biosciences (RNA) United States $0.965B 0.00
Inhibrx (INBX) United States $0.923B 0.00
Travere Therapeutics (TVTX) United States $0.912B 0.00
G1 THERAPEUTICS (GTHX) United States $0.910B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.905B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.905B 0.00
Merus (MRUS) Netherlands $0.887B 0.00
Epizyme (EPZM) United States $0.870B 0.00
Sutro Biopharma (STRO) United States $0.856B 0.00
Prometheus Biosciences (RXDX) United States $0.833B 0.00
Nkarta (NKTX) United States $0.822B 0.00
Affimed (AFMD) Germany $0.801B 0.00
Pharming Group (PHGUF) Netherlands $0.789B 21.00
Pharming Group (PHAR) Netherlands $0.775B 0.00
Verastem (VSTM) United States $0.774B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.762B 0.00
SESEN BIO, INC (SESN) United States $0.736B 0.00
Curis (CRIS) United States $0.733B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.722B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.715B 0.00
Kadmon Holdings (KDMN) United States $0.707B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.703B 0.00
ChromaDex (CDXC) United States $0.699B 0.00
Cara Therapeutics (CARA) United States $0.699B 60.70
Adaptimmune Therapeutics (ADAP) United Kingdom $0.693B 0.00
Cellectis S.A (CLLS) France $0.690B 0.00
IDEAYA Biosciences (IDYA) United States $0.687B 0.00
DBV Technologies S.A (DBVT) France $0.671B 0.00
AnaptysBio (ANAB) United States $0.665B 0.00
Clene (CLNN) United States $0.664B 0.00
Precision BioSciences (DTIL) United States $0.663B 0.00
MeiraGTx Holdings (MGTX) United States $0.660B 0.00
Sinovac Biotech (SVA) China $0.642B 6.47
ALBIREO PHARMA (ALBO) United States $0.639B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.634B 0.00
Anika Therapeutics (ANIK) United States $0.624B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.621B 0.00
Inventiva S.A (IVA) France $0.605B 0.00
Clovis Oncology (CLVS) United States $0.604B 0.00
Bolt Biotherapeutics (BOLT) United States $0.595B 0.00
Codiak BioSciences (CDAK) United States $0.591B 0.00
Adagene (ADAG) China $0.589B 0.00
Selecta Biosciences (SELB) United States $0.563B 0.00
AC Immune SA (ACIU) Switzerland $0.558B 0.00
Forte Biosciences (FBRX) United States $0.552B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.545B 0.00
Compugen (CGEN) Israel $0.543B 0.00
Starpharma Holdings (SPHRY) Australia $0.542B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.510B 0.00
XBiotech (XBIT) United States $0.509B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.503B 0.00
Gritstone Bio (GRTS) United States $0.495B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.494B 0.00
Athenex (ATNX) United States $0.469B 0.00
CytomX Therapeutics (CTMX) United States $0.465B 0.00
RAPT THERAPTICS (RAPT) United States $0.464B 0.00
Geron (GERN) United States $0.459B 0.00
Puma Biotechnology (PBYI) United States $0.458B 0.00
Spero Therapeutics (SPRO) United States $0.457B 0.00
Oncobiologics (OTLK) United States $0.451B 0.00
BeyondSpring (BYSI) United States $0.447B 0.00
Neoleukin Therapeutics (NLTX) United States $0.440B 0.00
Fortress Biotech (FBIO) United States $0.437B 0.00
AquaBounty Technologies (AQB) United States $0.433B 0.00
ANI Pharmaceuticals (ANIP) United States $0.431B 11.89
Amryt Pharma (AMYT) United Kingdom $0.419B 0.00
Cue Biopharma (CUE) United States $0.418B 0.00
Kala Pharmaceuticals (KALA) United States $0.409B 0.00
Angion Biomedica (ANGN) United States $0.399B 0.00
Opthea (OPT) Australia $0.387B 0.00
SQZ Biotechnologies (SQZ) United States $0.378B 0.00
Adicet Bio (ACET) United States $0.374B 0.00
Syros Pharmaceuticals (SYRS) United States $0.366B 0.00
Adverum Biotechnologies (ADVM) United States $0.364B 0.00
Athersys (ATHX) United States $0.362B 0.00
UROGEN PHARMA (URGN) United States $0.362B 0.00
WAVE Life Sciences (WVE) Singapore $0.361B 0.00
BioDelivery Sciences (BDSI) United States $0.360B 14.60
XOMA (XOMA) United States $0.356B 166.05
Trevena (TRVN) United States $0.348B 0.00
Prima BioMed (IMMP) Australia $0.342B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.339B 0.00
Theratechnologies (THTX) Canada $0.335B 0.00
Cerecor (CERC) United States $0.330B 0.00
Frequency Therapeutics (FREQ) United States $0.330B 0.00
Innate Pharma S.A (IPHA) France $0.327B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.324B 0.00
Arbutus Biopharma (ABUS) United States $0.316B 0.00
CorMedix Inc (CRMD) United States $0.313B 0.00
Cogent Biosciences (COGT) United States $0.312B 0.00
OVID THERAPEUTC (OVID) United States $0.304B 2.99
Talis Biomedical (TLIS) United States $0.299B 0.00
Cardiff Oncology (CRDF) United States $0.296B 0.00
Kindred Biosciences (KIN) United States $0.288B 0.00
Kaleido Biosciences (KLDO) $0.287B 0.00
PDL BioPharma (PDLI) United States $0.283B 0.00
Fulcrum Therapeutics (FULC) United States $0.282B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.273B 0.00
Bellus Health (BLU) Canada $0.270B 0.00
INmune Bio (INMB) United States $0.267B 0.00
Seelos Therapeutics (SEEL) United States $0.264B 0.00
Kamada (KMDA) Israel $0.263B 17.88
HOOKIPA Pharma (HOOK) United States $0.257B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.248B 0.00
Chiasma (CHMA) United States $0.243B 0.00
Aptinyx (APTX) United States $0.239B 0.00
Checkpoint Therapeutics (CKPT) United States $0.238B 0.00
ADMA Biologics Inc (ADMA) United States $0.233B 0.00
NextCure (NXTC) United States $0.222B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.220B 0.00
VTv Therapeutics (VTVT) United States $0.217B 0.00
X4 Pharmaceuticals (XFOR) United States $0.207B 0.00
POXEL SA FRANCE (PXXLF) France $0.197B 0.00
Synlogic (SYBX) United States $0.194B 0.00
Strongbridge Biopharma (SBBP) United States $0.193B 0.00
OSMOTICA PHARM (OSMT) United States $0.192B 0.00
Biofrontera AG (BFRA) Germany $0.190B 0.00
GENFIT S.A (GNFT) France $0.187B 0.00
TELA Bio (TELA) United States $0.184B 0.00
ObsEva SA (OBSV) Switzerland $0.184B 0.00
Applied Genetic Technologies (AGTC) United States $0.182B 0.00
Abeona Therapeutics (ABEO) United States $0.180B 0.00
Voyager Therapeutics (VYGR) United States $0.178B 4.59
Clearside Biomedical (CLSD) United States $0.173B 0.00
Galena Biopharma (SLS) United States $0.172B 0.00
Nicox SA (NICXF) France $0.171B 0.00
DiaMedica Therapeutics (DMAC) United States $0.168B 0.00
PHASEBIO PHARMA (PHAS) United States $0.168B 0.00
Eton Pharmaceuticals (ETON) United States $0.166B 0.00
Yumanity Therapeutics (YMTX) United States $0.165B 0.00
Antibe Therapeutics (ATBPF) Canada $0.163B 0.00
Enzo Biochem (ENZ) United States $0.149B 44.00
Exicure (XCUR) United States $0.148B 0.00
LogicBio Therapeutics (LOGC) United States $0.148B 0.00
Liminal BioSciences (LMNL) Canada $0.145B 0.00
Liquidia Technologies (LQDA) United States $0.141B 0.00
Catalyst Biosciences (CBIO) United States $0.141B 0.00
Erytech Pharma SA (ERYP) France $0.141B 0.00
Eyenovia (EYEN) United States $0.141B 0.00
F-star Therapeutics (FSTX) United Kingdom $0.139B 0.00
Pluristem Therapeutics (PSTI) Israel $0.138B 0.00
Aytu BioPharma (AYTU) United States $0.137B 0.00
Novogen (KZIA) Australia $0.136B 0.00
Cyclerion Therapeutics (CYCN) United States $0.136B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.134B 0.00
Longeveron (LGVN) United States $0.134B 0.00
Orgenesis (ORGS) United States $0.134B 273.50
Celsion (CLSN) United States $0.133B 0.00
Evofem Biosciences (EVFM) United States $0.129B 0.00
ABVC BioPharma (ABVC) United States $0.127B 0.00
Vascular Biogenics (VBLT) Israel $0.125B 0.00
Cocrystal Pharma (COCP) United States $0.122B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.120B 0.00
Aptevo Therapeutics (APVO) United States $0.115B 0.00
Beyond Air (XAIR) United States $0.113B 0.00
Vyant Bio (VYNT) United States $0.109B 0.00
ARAVIVE, INC (ARAV) United States $0.109B 0.00
CytRx (CYTR) United States $0.108B 0.00
Leap Therapeutics (LPTX) United States $0.107B 0.00
Cidara Therapeutics (CDTX) United States $0.104B 0.00
Dyadic (DYAI) United States $0.101B 0.00
TRACON Pharmaceuticals (TCON) United States $0.101B 0.00
Zosano Pharma (ZSAN) United States $0.100B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.098B 0.00
AIkido Pharma (AIKI) United States $0.098B 0.00
Lumos Pharma (LUMO) United States $0.096B 0.00
Evogene (EVGN) Israel $0.093B 0.00
Cleveland BioLabs (CBLI) United States $0.090B 0.00
Entera Bio (ENTX) Israel $0.090B 0.00
Stealth BioTherapeutics (MITO) Cayman Islands $0.089B 0.00
Purple Biotech (PPBT) Israel $0.088B 0.00
Celyad SA (CYAD) Belgium $0.083B 0.00
ARIDIS PHARMACT (ARDS) United States $0.078B 0.00
Edesa Biotech (EDSA) Canada $0.077B 0.00
Adocia (ADOCY) France $0.077B 0.00
ATyr Pharma (LIFE) United States $0.076B 0.00
Vaccinex (VCNX) United States $0.075B 0.00
BioCardia (BCDA) United States $0.073B 0.00
Alimera Sciences (ALIM) United States $0.071B 0.00
Advaxis (ADXS) United States $0.071B 0.00
Emmaus Life Sciences (EMMA) United States $0.071B 0.00
Cyclo Therapeutics (CYTH) United States $0.069B 0.00
Genetic Technologies (GENE) Australia $0.068B 0.00
AEterna Zentaris (AEZS) United States $0.066B 0.00
Idera Pharmaceuticals (IDRA) United States $0.066B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.065B 0.00
Pulmatrix (PULM) United States $0.064B 0.00
Windtree Therapeutics (WINT) United States $0.064B 0.00
Viridian Therapeutics (VRDN) United States $0.063B 0.00
Organovo Holdings (ONVO) United States $0.061B 0.00
Invo BioScience (INVO) United States $0.054B 0.00
AnPac Bio-Medical Science (ANPC) China $0.054B 0.00
Enveric Biosciences (ENVB) United States $0.051B 0.00
Soligenix (SNGX) United States $0.047B 0.00
Happiness Biotech Group (HAPP) China $0.043B 0.00
Benitec Biopharma (BNTC) United States $0.037B 0.00
Acorda Therapeutics (ACOR) United States $0.037B 0.88
ThermoGenesis Holdings (THMO) United States $0.035B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.034B 0.00
GeoVax Labs (GOVX) United States $0.034B 0.00
Vallon Pharmaceuticals (VLON) United States $0.034B 0.00
Lexaria Bioscience (LEXX) Canada $0.033B 0.00
Prana Biotechnology (ATHE) Australia $0.032B 0.00
IMMURON (IMRN) Australia $0.028B 0.00
Titan Pharmaceuticals (TTNP) United States $0.025B 0.00
ZIVO Bioscience (ZIVO) United States $0.025B 0.00
Palisade Bio (PALI) United States $0.012B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.000B 0.00
ImmunityBio (IBRX) United States $0.000B 0.00
Immatics (IMTX) United States $0.000B 0.00